BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24989719)

  • 1. An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population.
    McGeechan K; Macaskill P; Irwig L; Bossuyt PM
    BMC Med Res Methodol; 2014 Jul; 14():86. PubMed ID: 24989719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III.
    Zalawadiya SK; Veeranna V; Mallikethi-Reddy S; Bavishi C; Lunagaria A; Kottam A; Afonso L
    Eur J Prev Cardiol; 2015 Apr; 22(4):513-8. PubMed ID: 24431384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.
    Cook NR; Ridker PM
    Ann Intern Med; 2009 Jun; 150(11):795-802. PubMed ID: 19487714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining risk markers improves cardiovascular risk prediction in women.
    Holewijn S; den Heijer M; Kiemeney LA; Stalenhoef AF; de Graaf J
    Clin Sci (Lond); 2014 Jan; 126(2):139-46. PubMed ID: 23879211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Net reclassification index at event rate: properties and relationships.
    Pencina MJ; Steyerberg EW; D'Agostino RB
    Stat Med; 2017 Dec; 36(28):4455-4467. PubMed ID: 27426413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk.
    Bell K; Hayen A; McGeechan K; Neal B; Irwig L
    Eur J Prev Cardiol; 2012 Dec; 19(6):1474-85. PubMed ID: 21947629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the nonlaboratory-based Framingham cardiovascular disease risk assessment algorithm in the Atherosclerosis Risk in Communities dataset.
    Kariuki JK; Stuart-Shor EM; Leveille SG; Gona P; Cromwell J; Hayman LL
    J Cardiovasc Med (Hagerstown); 2017 Dec; 18(12):936-945. PubMed ID: 29045312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Long-term Cumulative Blood Pressure in Cardiovascular Risk Prediction Models.
    Pool LR; Ning H; Wilkins J; Lloyd-Jones DM; Allen NB
    JAMA Cardiol; 2018 Nov; 3(11):1096-1100. PubMed ID: 30193291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data Sets.
    Pepe MS; Fan J; Feng Z; Gerds T; Hilden J
    Stat Biosci; 2015 Oct; 7(2):282-295. PubMed ID: 26504496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Net risk reclassification p values: valid or misleading?
    Pepe MS; Janes H; Li CI
    J Natl Cancer Inst; 2014 Apr; 106(4):dju041. PubMed ID: 24681599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-linear contribution of glucose measures to cardiovascular diseases and mortality: reclassifying the Framingham's risk categories: a decade follow-up from the Tehran lipid and glucose study.
    Yadegari H; Bozorgmanesh M; Hadaegh F; Azizi F
    Int J Cardiol; 2013 Aug; 167(4):1486-94. PubMed ID: 22578948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discriminative ability, reclassification and net benefit: the predictive value of biomarkers].
    Steyerberg EW; Pencina MJ; Van Calster B
    Ned Tijdschr Geneeskd; 2012; 156(41):A5029. PubMed ID: 23062255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III.
    Shah N; Pahuja M; Pant S; Handa A; Agarwal V; Patel N; Dusaj R
    Int J Cardiol; 2017 Apr; 232():105-110. PubMed ID: 28117138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis.
    Yeboah J; Carr JJ; Terry JG; Ding J; Zeb I; Liu S; Nasir K; Post W; Blumenthal RS; Budoff MJ
    Eur J Prev Cardiol; 2014 Oct; 21(10):1233-41. PubMed ID: 23689526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical risk reclassification at 10 years.
    Cook NR; Demler OV; Paynter NP
    Stat Med; 2017 Dec; 36(28):4498-4502. PubMed ID: 29156504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary information improves cardiovascular disease risk prediction models.
    Baik I; Cho NH; Kim SH; Shin C
    Eur J Clin Nutr; 2013 Jan; 67(1):25-30. PubMed ID: 23149979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.
    Van Calster B; Vickers AJ; Pencina MJ; Baker SG; Timmerman D; Steyerberg EW
    Med Decis Making; 2013 May; 33(4):490-501. PubMed ID: 23313931
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.